Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II Trial

Published 2011 View Full Article

Authors

Keywords

Journal

CLINICAL CANCER RESEARCH

Volume 17, Issue 21, Pages 6847-6857

Publisher

American Association for Cancer Research (AACR)

Online

2011-09-15

DOI

10.1158/1078-0432.ccr-11-1385

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

CLINICAL CANCER RESEARCH

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find Funding. Review Successful Grants.

Ask a Question. Answer a Question.